Boji Medical Technology Co.,Ltd. (SHE:300404)

Boji Medical Technology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	752.09	723.92	541.59	411.06	314.65	257.15
Other Revenue	18.1	18.1	14.24	12.62	9.55	3.32
Revenue	770.19	742.02	555.83	423.68	324.2	260.47
Revenue Growth (YoY)	2.26%	33.50%	31.19%	30.69%	24.47%	16.25%
Cost of Revenue	556.69	517.98	373.34	267.57	185.56	148.54
Gross Profit	213.5	224.04	182.49	156.11	138.64	111.93
Selling, General & Admin	125.97	124.44	108.99	88.65	71.19	56.07
Research & Development	57.07	62.59	54.97	43.68	27.65	26.44
Other Operating Expenses	7.45	6.62	3.24	2.8	2.27	1.68
Operating Expenses	212.62	214.03	182.56	150.05	109.43	94.87
Operating Income	0.88	10	-0.07	6.06	29.22	17.06
Interest Expense	-1.88	-3.19	-1.53	-0.7	-1.41	-1.48
Interest & Investment Income	1.84	4.28	4.33	3.64	4.21	3.33
Currency Exchange Gain (Loss)	0	0	-0.01	-0.01	-0.01	0.01
Other Non Operating Income (Expenses)	-2.28	-2.34	-0.59	-0.41	-0.4	0.29
EBT Excluding Unusual Items	-1.44	8.76	2.12	8.58	31.61	19.21
Gain (Loss) on Sale of Investments	1.39	1.06	0.59	1.79	-	-
Gain (Loss) on Sale of Assets	-0.22	-0.21	0	-	-	-
Asset Writedown	-2.76	-0.08	-0.03	-0.07	-0.3	-
Other Unusual Items	8.61	8.89	14.95	14.27	15.78	8.56
Pretax Income	5.59	18.42	17.63	24.57	47.09	27.77
Income Tax Expense	-3.58	-12.24	-9.56	-4.74	3.59	2.9
Earnings From Continuing Operations	9.16	30.66	27.19	29.31	43.5	24.87
Minority Interest in Earnings	-1.75	-1.88	-2.85	-1.64	-4.62	-7.88
Net Income	7.41	28.78	24.34	27.67	38.88	16.99
Net Income to Common	7.41	28.78	24.34	27.67	38.88	16.99
Net Income Growth	-83.38%	18.23%	-12.04%	-28.84%	128.87%	157.69%
Shares Outstanding (Basic)	384	382	370	367	349	317
Shares Outstanding (Diluted)	384	383	371	367	349	318
Shares Change (YoY)	0.70%	3.14%	0.97%	5.18%	10.02%	-0.29%
EPS (Basic)	0.02	0.08	0.07	0.08	0.11	0.05
EPS (Diluted)	0.02	0.08	0.07	0.08	0.11	0.05
EPS Growth	-83.49%	14.63%	-12.88%	-32.34%	108.04%	158.45%
Free Cash Flow	31.66	-2.57	-26.24	-89.59	-23.89	65.64
Free Cash Flow Per Share	0.08	-0.01	-0.07	-0.24	-0.07	0.21
Dividend Per Share	0.012	0.012	0.010	0.010	0.014	-
Dividend Growth	20.00%	20.00%	-	-30.07%	-	-
Gross Margin	27.72%	30.19%	32.83%	36.85%	42.77%	42.97%
Operating Margin	0.11%	1.35%	-0.01%	1.43%	9.01%	6.55%
Profit Margin	0.96%	3.88%	4.38%	6.53%	11.99%	6.52%
Free Cash Flow Margin	4.11%	-0.35%	-4.72%	-21.15%	-7.37%	25.20%
EBITDA	27.65	34.07	20.4	24.99	46.03	32.05
EBITDA Margin	3.59%	4.59%	3.67%	5.90%	14.20%	12.31%
D&A For EBITDA	26.77	24.07	20.47	18.93	16.81	15
EBIT	0.88	10	-0.07	6.06	29.22	17.06
EBIT Margin	0.11%	1.35%	-0.01%	1.43%	9.01%	6.55%
Effective Tax Rate	-	-	-	-	7.62%	10.45%
Revenue as Reported	770.19	742.02	555.83	423.68	324.2	260.47
Advertising Expenses	-	2.29	1.85	0.71	0.65	0.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.